Roles of Aurora-A in tumorigenesis and prognosis of breast cancer

Chinese Journal of Cancer

Volumn 28, Issue 6, 2009, Pages

  Xia, Liang Ping ^a   Zhou, Fei Fei ^a   Yang, Ming Tian ^a   Liu, Qiang ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Aurora kinase; Breast neoplasm; Prognosis; Tumorigenesis

Indexed keywords

ANTINEOPLASTIC AGENT; AURORA A KINASE; AURORA B KINASE; BRCA1 PROTEIN; ESTROGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN P53; TAMOXIFEN;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER CHEMOTHERAPY; DNA POLYMORPHISM; EARLY CANCER; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME POLYMORPHISM; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENOMIC INSTABILITY; HUMAN; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 79955761316     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Liu Q, Ruderman JV, Aurora A, mitotic entry, and spindle bipolarity [J], Proc Natl Acad Sci USA, 2006, 103 (15): 5811-5816.
2. Fu J, Bian M, Jiang Q, et al. Roles of Aurora kinases in mitosis and tumorigenesis [J]. Mol Cancer Res, 2007, 5 (1): 1-10.
3. Zhou H, Kuang J, Zhong L, et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation [J]. Nat Genet, 1998, 20(2): 189-193.
4. Bischoff JR, Anderson L, Zhu Y, et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers [J]. EMBO J, 1998, 17: 3052-3065.
5. Sen S, Zhou H, White RA. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines [J]. Oncogene, 1997, 14(18): 2195-2200.
6. Wang X, Zhou YX, Qiao W, et al. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation [J]. Oncogene, 2006, 25(54): 7148-7158.
7. Zhang D, Hirota T, Marumoto T, et al. Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models [J]. Oncogene, 2004, 23 (54): 8720-8730.
8. Katayama H, Sadai K, Kawai H, et al. Phosphorylation by aurora kinase A induces mda2-mediated destabilization and inhibition of p53 [J]. Nat Genet, 2004, 36(1): 55-62.
9. Liu Q, Kaneko S, Yang L, et al. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215 [J]. J Biol Chem, 2004, 279(50): 52175-52182.
10. Sankaran S, Crone DE, Palazzo RE, et al. Aurora-A kinase regulates breast cancer associated gene 1 inhibition of centrosome-dependent microtubule nucleation [J]. Cancer Res, 2007, 67(23): 11186-11194.
11. Egan KM, Newcomb PA, Ambrosone CB, et al. STK15 polymorphism and breast cancer risk in a population-based study [J]. Carcinogenesis, 2004, 25(11): 2149-2153.
12. Cox DG, Hankinson SE, Hunter DJ. Polymorphisms of the AURKA (STK15/aurora kinase) gene and breast cancer risk (United States) [J]. Cancer Causes Control, 2006, 17(1): 81-83.
13. Dai Q, Cai QY, Shu XO, et al. Synergistic effects of STK15 gene polymorphisms and endogenous estrogen exposure in the risk of breast cancer [J]. Cancer Epidemiol Biomarkers Prev, 2004, 13(12): 2065-2070.
14. Lo YL, Yu JC, Chen ST, et al. Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK [J]. Int J Cancer, 2005, 115 (2): 276-283.
15. Ewart-Toland A, Dai Q, Gao YT, et al. Aurora-A/ STK15 T+ 91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types [J]. Carcinogenesis, 2005, 26(8): 1368-1373.
16. Fletcher O, Johnson N, Palles C, et al. Inconsistent association between the STK15 F311 genetic polymorphism and breast cancer risk [J]. J Natl Cancer Inst, 2006, 98 (14): 1014-1048.
17. Sun T, Miao X, Wang J, et al. Functional Phe31 Ile polymorphism in Aurora A and risk of breast carcinoma [J]. Carcinogenesis, 2004, 25 (11): 2225-2230.
18. Hoque A, Carter J, Xia W, et al. Loss of aurora A/STK15/ BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast [J]. Cancer Epidemiol Biomarkers Prev, 2003, 12(12): 1518-1522.
19. Goepfert T, Adigun YE, Zhong L, et al. Centrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis [J]. Cancer Res, 2002, 62 (14): 4115-4122.
20. Gritsko TM, Coppola D, Paciga JE, et al. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer [J]. Clin Cancer Res, 2003, 9(4): 1420-1426.
21. Tanaka T, Kimura M, Matsunaga K, et al. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast [J]. Cancer Res, 1999, 59(9): 2041-2044.
22. Li JJ, Weroha SJ, Lingle WL, et al. Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats [J]. Proc Natl Acad Sci USA, 2004, 101 (52): 18123-18128.
23. Hodges LC, Cook JD, Lobenhofer EK, et al. Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells [J]. Mol Cancer Res, 2003, 1 (4): 300-311.
24. Li JJ, Papa D, Davis MF, et al. Ploidy differences between hormone-and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer [J]. Mol Carcinog, 2002, 3 (1): 56-65.
25. Li SA, Weroha SJ, Li JJ. Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation [J]. J Endocrinol, 2002, 175 (2): 297-305.
26. Lee HH, Zhu Y, Govindasamy KM, et al. Downregulation of Aurora-A overrides estrogen-mediated growth and chemoresistance in breast cancer cells [J]. Endocr Relat Cancer, 2008, 15(3): 765-775.
27. Nadler Y, Camp RL, Schwartz C, et al. Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer [J]. Clin Cancer Res, 2008, 14 (14): 4455-4462.
28. Royce ME, Xia W, Sahin AA, et al. STK15/Aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis [J]. Cancer, 2004, 100 (1): 12-19.
29. Miyoshi Y, Iwao K, Egawa C, et al. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers [J]. Int J Cancer, 2001, 92 (3): 370-373.
30. Long ZJ, Xu J, Yan M, et al. ZM 447439 inhibition of aurora kinase induces Hep2 cancer cell apoptosis in three-dimensional culture [J]. Cell Cycle, 2008, 7(10): 1473-1479.
31. Carpinelli P, Ceruti R, Giorgini ML, et al. PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer [J]. Mol Cancer Ther, 2007, 6(12 Pt 1): 3158-3168.
32. Gautschi O, Heighway J, Mack PC, et al. Aurora Kinases as anticancer drug targets [J]. Clin Cancer Res, 2008, 14 (6): 1639-1648.
33. Agnese V, Bazan V, Fiorentino FP, et al. The role of Aurora-A inhibitors in cancer therapy [J]. Ann Oncol, 2007, 18 (Suppl 6): vi47-52.